kras mutation and glutathion glynac Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients? Targeting mutated GTPase KRAS in
Targeting mutated GTPase KRAS in tumor therapies ScienceDirect Isoform Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D: Cell Reports Pancreatic Cancer: Advances and Challenges PMC Oncometabolites in pancreatic cancer: Strategies and its implications PMC
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



